Compared with high-intensity statin therapy, moderate intensity statin therapy plus ezetimibe was equally effective in preventing CV events among patients undergoing PCI. Moderate-intensity statin ...

Results from the largest community-based clinical trial to date, involving more than 3000 patients, has shown that adding the cholesterol absorption inhibitor ezetimibe to ongoing stable statin ...

Merck's experimental cholesterol buster easily outperformed a triplet of medications, the Dow Jones component said Monday.

Thousands of lives could be saved by changing the rules around prescribing statins, according to research. The largest analysis to examine the best way to lower levels of "bad" cholesterol in patients ...

The study was a randomized, placebo-controlled comparison of the effects of daily treatment with fenofibrate 160 mg, ezetimibe-simvastatin 10/20 mg, ezetimibe-simvastatin 10/20 mg plus fenofibrate 160 ...

Please provide your email address to receive an email when new articles are posted on . Lerodalcibep, an investigational PCSK9 inhibitor, decreased LDL cholesterol on top of existing oral agents ...

London, UK: The largest analysis to examine the best way to lower levels of ‘bad’ cholesterol in patients with blocked arteries shows that they should immediately be given a combination of a statin ...